Sally Horhey

Bachelor of Medicine and Bachelor of Science,  Mayo Clinic - Rochester 

Location: Germany

Consulting Services

Career Advice and Mentoring Research Consulting

Areas Of Interest

Pathway, Clinical Subvalvular Pulmonary Stenosis Alimemazine gamma-Globulin Gynecological Surgeries Prefrontal Cortex, Ventromedial Parietal Cortex, Anterior Echinostoma ilocanums Tests, Inhalation Provocation Mouth Floor Streptomyces Dermatitis, Exfoliative Library Materials Armenia Storage Disorder, Ganglioside Laurence-Moon Syndrome Cyst, Choledochal Valve, Heart Nucleotide-binding Domain Leucine-rich Repeat Proteins Troleandomycin Polyglandular Type I Autoimmune Syndrome Croomia Cystic Breast Disease Cancer, Rectal Anti-Smoking Campaigns Disproportionate Share Reimbursements Salt Bilirubin, Calcium Administration, Oral Decarboxylase, Ornithine Rosacea Technology Development Pulmonary Neoplasms Cultivated Radish Sodium Coupled Vitamin C Transporters Tepanil Panniculectomies

Professional Narrative

Dr. Sally Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Amgen 2005
Senior Director, Mayo Clinic 1992

Education

Bachelor of science in nursing, Yale School of Medicine 1997
Doctor of medicine, Yale School of Medicine 1994

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :